FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (FOXO) is a post-merger insurtech company that entered public markets through a SPAC combination with CF Acquisition Corp VIII, sponsored by Cantor Fitzgerald, which conducted its blank-check IPO in 2021. The company focuses on applying epigenetic biomarker science to life insurance underwriting, positioning itself at the intersection of biotechnology and insurance technology. On February 9, 2026, FOXO filed an S-1 registration statement with the Securities and Exchange Commission under accession number 0001493152-26-005646, reflecting continued activity in the public capital markets. For complete filing history, corporate status updates, and institutional-grade SPAC analytics on FOXO and hundreds of other issuers, sign up for full access at SpacDesk.